A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...
Neurosurgeon and scientist Dr. Jandial joined us to discuss a major breakthrough in pain medication recently approved by the ...
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another ...
Drug compounders sued the U.S. Food and Drug Administration on Monday over its decision last week to remove Novo Nordisk's ...
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
FP008 is designed for patients with solid tumors that have not responded to existing immunotherapies targeting PD-1.
Several rare disease patient populations received their first-ever FDA-approved drug since Rare Disease Day last year, ...
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...
The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday.  Patrizia Cavazzoni was formerly director of ...